With Christmas just around the corner, it is only natural to reflect on the changes and trends of 2021 as we move closer to the new year. WInter is always challenging for the healthcare sector and this year it is particularly so, due to winter pressures coupled with the ongoing issues associated with COVID-19. However, there is still much to celebrate and reflect on as we head into 2022, and much to read in our latest issue.
Maddy Farnworth examines how the pandemic has brought into sharp focus the importance of long-term sustainability and resilience of health systems. In her article, she considers three interconnected areas where the pharma industry needs to focus its attention to demonstrate its continued commitment to working for good.
OVID Health’s Jenny Ousbey also considers how sustainability has taken the spotlight in 2021 for the healthcare communications industry, with 2022 shaping up to be an important year for the sector to demonstrate its commitment to progress.
Often misunderstood, the new focus on prevention and population health within the NHS can help pharma become a critical part of a more holistic, outcomes-led strategy for local systems, argues Oli Hudson
PharmaTimes talks to Filippo Buccella, whose son Luca was diagnosed with the rare genetic disorder Duchenne muscular dystrophy (DMD) 28 years ago.He offers an in-depth look at Luca’s path to diagnosis, the treatment he has received as well as the advice he would offer to parents of a child with DMD.
What job are you looking for?
Marketer, Communications Team of the year and Sales awards